H-Index
70
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Underexpression of CACNA1C Caused by Overexpression of microRNA-29a Underlies the Pathogenesis of Atrial Fibrillation

Yujie Zhao, Yiqiang Yuan, Chunguang Qiu

(Department of Cardiovascular, No. 7 People’s Hospital in Zhengzhou, Zhengzhou, Henan, China (mainland))

Med Sci Monit 2016; 22:2175-2181

DOI: 10.12659/MSM.896191

Published: 2016-06-24


BACKGROUND: The objective of this study was to investigate the molecular mechanism of atrial fibrillation (AF), as well as the negative regulatory relationship between miR-29a-3p and CACNA1C.
MATERIAL AND METHODS: We searched the online miRNA database (www.mirdb.org) and identified the miR-29a-3p binding sequence within the 3’-UTR of the target gene, and then conducted luciferase assay to verify it. The cells were transfected with miR-29a-3p and ICa,L was determined in those cells.
RESULTS: We validated CACNA1C to be the direct target gene of miR-29a-3p. We also established the negative regulatory relationship between miR-29a-3p and CACNA1C via studying the relative luciferase activity. We also conducted real-time PCR and Western blot analysis to study the mRNA and protein expression level of CACNA1C among different groups of cells treated with scramble control, 30nM miR-29a-3p mimics, and 60nM miR-29a-3p mimics, indicating a negative regulatory relationship between miR-29a-3p and CACNA1C. We next analyzed whether miR-29a-3p transfection in cardiomyocytes produced the effects on the ICa,L induced by electrical remodeling, and found a tonic inhibition of IBa by endogenous miR-29a-3p in atrial myocytes.
CONCLUSIONS: We validated the negative regulation between miR-29a-3p and CACNA1C, and found that miR-29a-3p might a potential therapeutic target in the treatment of AF.

Keywords: Atrial Fibrillation - pathology, 3' Untranslated Regions, Calcium Channels, L-Type - metabolism, Case-Control Studies, Down-Regulation, Gene Expression Regulation, Humans, MicroRNAs - metabolism, Myocytes, Cardiac - pathology, RNA, Messenger - metabolism, Transfection



Back